Key result
Surgical PE management yields ~1% mortality in high-risk submassive vs 12% in massive PE.
Why the study?
Does surgical management (embolectomy or venoarterial ECMO) improve right ventricular function and survival in patients with acute massive or high-risk submassive pulmonary embolism?
Cohort (n=136)
Does surgical management (embolectomy or venoarterial ECMO) improve right ventricular function and survival in patients with acute massive or high-risk submassive pulmonary embolism?
Answers are grounded in this paper and cite their sources.
Surgical management of acute massive and high-risk submassive pulmonary embolism is associated with low mortality and significant improvement in right ventricular function.
BACKGROUND Acute pulmonary embolism (PE) is associated with high morbidity and mortality because of right ventricular (RV) failure. There is evidence suggesting surgical therapy (surgical embolectomy or venoarterial extracorporeal membrane oxygenation [ECMO]) is safe and effective. OBJECTIVES The aim of this study was to assess the safety and efficacy of surgical management of acute PE. METHODS Surgical embolectomy and/or venoarterial ECMO were compared, between 2005 and 2019, for massive PE (MPE) versus high-risk submassive PE (SMPE). RV recovery was defined as improvements in central venous pressure, pulmonary artery systolic pressure, RV/left ventricular ratio, and RV fractional area change. RESULTS One hundred thirty-six patients with PE (92 with SMPE and 44 with MPE) were identified. Patients with MPE more often presented with syncope (59.1% [26 of 44] vs. 25.0% [23 of 92]; p = 0.0003), Glasgow Coma Scale score ≤4 (22.7% [10 of 44] vs. 0% [0 of 92]), and failed thrombolysis (18.2% [8 of 44] vs. 4.3% [3 of 92]; p = 0.008). Pre-operative cardiopulmonary resuscitation occurred in 43.2% of patients with MPE (19 of 44). Most patients with SMPE were treated with embolectomy (98.9% [91 of 92]), while ECMO was used more in those with MPE (ECMO in 40.9% [18 of 44], embolectomy in 59.1% [26 of 44]). RV function improved as measured by central venous pressure (from 23.4 ± 4.9 to 10.5 ± 3.1 mm Hg), pulmonary artery systolic pressure (from 60.6 ± 14.2 to 33.8 ± 10.7 mm Hg), RV/left ventricular ratio (from 1.19 ± 0.33 to 0.87 ± 0.23; p < 0.005), and fractional area change (from 26.8 to 41.0; p < 0.005). Mortality was 4.4% (6 of 136; SMPE, 1.1% [1 of 92]; MPE, 11.6% [5 of 44]). Subgroup analysis showed morbidity and mortality were highly associated with pre-operative cardiopulmonary resuscitation. CONCLUSIONS Surgical management of patients with MPE and high-risk SMPE is safe and highly effective at achieving RV recovery.
No takes yet. Share an insight, caveat, or question.
Goldberg et al. (2020) conducted a cohort in Acute pulmonary embolism (n=136). Massive pulmonary embolism (MPE) vs. High-risk submassive pulmonary embolism (SMPE) was evaluated on Mortality. In patients undergoing surgical management for acute pulmonary embolism, mortality was 11.6% for massive PE compared to 1.1% for high-risk submassive PE, alongside significant right ventricular recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: